Jelle Wesseling
0000-0002-8940-2676
8 papers found
Refreshing results…
Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments
Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists
Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression
Endonuclease FEN1 coregulates ERα activity and provides a novel drug interface in tamoxifen resistant breast cancer
Prognostic Value of Residual Disease after Neoadjuvant Therapy in HER2-Positive Breast Cancer Evaluated by Residual Cancer Burden, Neoadjuvant Response Index, and Neo-Bioscore
EZH2 Is Overexpressed in BRCA1-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy
Missing publications? Search for publications with a matching author name.